Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.091
Delayed Data
As of 12:26pm ET
 -0.001 / -1.09%
Today’s Change
0.06
Today|||52-Week Range
0.25
-1.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-96.6M28.9M-683.0K3.8M
 
 
 
 
 
Depreciation453.7K581.9K666.5K700.4K
 
 
 
 
 
Total Other Cash Flow91.9M-44.5M-4.6M-7.8M
 
 
 
 
 
Funds From Operations-4.2M-14.9M-4.6M-3.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-32.0K163.1K-1.9M4.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-4.2M-15.1M-2.8M-7.9M
 
 
 
 
 
 
InvestingIncrease In Investments0.00--0.00-122.00
 
 
Decrease In Investments0.005.0M0.000.00
 
 
Capital Expenditures-502.3K-2.0M-1.9M-1.1M
 
 
 
 
 
Other Investing - Sources2.8K-123.9K----
 
 
 
Net Cash Flow Investing-557.7K2.9M-1.9M-1.1M
 
 
 
 
 
 
FinancingShort Term Borrowings527.2K-164.7K135.2K-718.3K
 
 
 
 
 
Long Term Borrowings0.000.00------
Long Term Debt Reduction0.00-1.1M614.1K-621.5K
 
 
 
 
Net Proceeds Stock Sale10.9M14.0M9.2M9.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing1.000.000.000.00
 
 
Other Uses - Financing48.0K0.000.000.00
 
 
Net Cash Flow - Financing11.3M12.7M8.8M8.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash6.6M522.4K4.0M-917.5K